【索引编号】1-A0011【异名】Flaconitine【化学名】Aconitane-3,8,13,14,15-pentol,20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-,3,8-diacetate14-benzoate,(1α,3α,6α,14α,15α,16β)-【结构式】【CAS】77181-26-1【分子式及分子量】C36H49NO12;687.78【化学分类】萜生物碱...[继续阅读]
海量资源,尽在掌握
【索引编号】1-A0011【异名】Flaconitine【化学名】Aconitane-3,8,13,14,15-pentol,20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-,3,8-diacetate14-benzoate,(1α,3α,6α,14α,15α,16β)-【结构式】【CAS】77181-26-1【分子式及分子量】C36H49NO12;687.78【化学分类】萜生物碱...[继续阅读]
【索引编号】1-A0012【异名】Jervineacetate【化学名】Veratraman-11-one,3-(acetyloxy)-17,23-epoxy-(3β,23β)-【结构式】【CAS】14788-78-4【分子式及分子量】C29H41NO4;467.65【化学分类】甾体生物碱steroidalalkaloid【物理性状】无定形粉末,mp240℃,[α]D-120°...[继续阅读]
【索引编号】1-A0013【化学名】α-L-Arabinopyranoside,(3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-ylO-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[O-β-D-xylopyranosyl-(1→2)-6-O-acetyl-β-D-glucopyranosyl-(1→3)]-【结构式】【CAS】194737-13-8【分子式及分子量】C54H...[继续阅读]
【索引编号】1-A0014【化学名】1H-Cyclopenta[b]benzofuran-2-carboxamide,1-(acetyloxy)-2,3,3a,8b-tetrahydro-8b-hydroxy-3a-(3-hydroxy-4-methoxyphenyl)-6,8-dimethoxy-N,N-dimethyl-3-phenyl-[1R-(1α,2α,3β,3αβ,8bβ)]-【结构式】【CAS】189322-68-7【分子式及分子量】C31H33NO9;563.6...[继续阅读]
【索引编号】1-A0015【化学名】Androst-2-en-1-one,5,6-epoxy-17-hydroxy-17-(4-hydroxy-4,5-dimethyl-3-oxo-2-oxabicyclo[3.2.1]oct-7-yl),[5β,6β,17β,17(1R,4R,5R,7S)]-【结构式】【CAS】77011-62-2【分子式及分子量】C28H38O6;470.61【化学分类】甾体steroid【物理性状】mp2...[继续阅读]
【索引编号】1-A0016【化学名】Androsta-2,4,6-trien-1-one,17-hydroxy-17-(4,4,5-trimethyl3-oxo-2-oxabicyclo[3.2.1]oct-7-yl)-,[17β,17(1R,5R,7S)]-【结构式】【CAS】157998-91-9【分子式及分子量】C28H36O5;452.59【化学分类】甾体steroid【物理性状】黄色固体,mp212℃(分...[继续阅读]
【索引编号】1-A0017【化学名】Androst-2-en-1-one,5,6-epoxy-4,17-dihydroxy-17-(4-hy-droxy-4,5-dimethyl-3-oxo-2-oxabicyclo[3.2.1]oct-7-yl),[4β,5β,6β,17β,17(1R,4R,5R,7S)]-【结构式】【CAS】76994-39-3【分子式及分子量】C28H38O7;486.61【化学分类】甾体steroid【物理性状...[继续阅读]
【索引编号】1-A0018【化学名】9(10H)-Acridinone,1,6-dihydroxy-3,5-dimethoxy-2-[1-(7-methoxy-2-oxo-2H-1-benzopyran-6-yl)-3-methyl-2-butenyl]-10-methyl-【结构式】【CAS】129722-89-0【分子式及分子量】C31H29NO8;543.57【化学分类】吖啶生物碱acridinealkaloid;香豆素coum...[继续阅读]